Pharmacy students' ability to recognize drug-drug interactions (DDIS)

被引：0
|
作者：
Saverno, K. [1 ]
Malone, D. C. [1 ]
机构：
[1] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70169-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A50 / A50
页数：1
相关论文
共 50 条
  • [1] Medical, nursing, and pharmacy students' ability to recognize potential drug-drug interactions: A comparison of healthcare professional students
    Warholak, Terri L.
    Hines, Lisa E.
    Song, Mi Chi
    Gessay, Austin
    Menke, J. Michael
    Sherrill, Duane
    Reel, Sally
    Murphy, John E.
    Malone, Daniel C.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2011, 23 (04): : 216 - 221
  • [2] Pharmacy Students' Ability to Identify Potential Drug-Drug Interactions
    Saverno, Kim R.
    Malone, Daniel C.
    Kurowsky, John
    [J]. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2009, 73 (02)
  • [3] Pharmacy Students' Retention of Knowledge of Drug-Drug Interactions
    Gilligan, Adrienne M.
    Warholak, Terri L.
    Murphy, John E.
    Hines, Lisa E.
    Malone, Daniel C.
    [J]. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2011, 75 (06)
  • [4] Analysis of drug-drug interactions (DDIs) in nursing homes in Central Taiwan
    Liao, Hui-Ling
    Chen, Jin-Tang
    Ma, Tso-Chiang
    Chang, Yuan-Shiun
    [J]. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2008, 47 (01) : 99 - 107
  • [5] How to recognize drug-drug interactions with therapeutic drug monitoring
    Baumann, P.
    [J]. EUROPEAN PSYCHIATRY, 2019, 56 : S657 - S658
  • [6] Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 3: Pharmacokinetic Considerations
    Preskorn, Sheldon H.
    [J]. JOURNAL OF PSYCHIATRIC PRACTICE, 2019, 25 (01) : 34 - 40
  • [7] Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 6: Pharmacodynamic Considerations
    Preskorn, Sheldon H.
    [J]. JOURNAL OF PSYCHIATRIC PRACTICE, 2019, 25 (04) : 290 - 297
  • [8] Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 2: Strategies to Minimize Adverse Outcomes From Unintended DDIs
    Preskorn, Sheldon H.
    [J]. JOURNAL OF PSYCHIATRIC PRACTICE, 2018, 24 (05) : 341 - 347
  • [9] Examining and improving senior pharmacy students' knowledge of clinically critical drug-drug interactions
    Oguz, Fatih
    Arslan, Miray
    [J]. PHARMACY EDUCATION, 2022, 22 (04): : 24 - 31
  • [10] PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING OF ELAGOLIX FOR PREDICTION OF DRUG-DRUG INTERACTIONS (DDIS)
    Chiney, M. S.
    Polepally, A. R.
    Nader, A. M.
    Dufek, M. B.
    Klein, C. E.
    Ng, J. W.
    Shebley, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S59 - S59
12345